Thomas Ruggia

Thomas Ruggia, CEO of Theialife, is a healthcare business leader who is passionate about improving patient lives by enhancing vision. With 25 years of ophthalmology business experience, he has comprehensive experiences in health care in the United States and around the world.

Tom joined Theialife from Samsara Vision where he was CEO for nearly 6 years. Prior to CEO experiences, Tom served at Johnson & Johnson, working at J&J Vision and The Janssen Pharma Co, respectively. Tom played a key role at J&J, as the commercial lead in the acquisition of AMO from Abbott. Previously, he spent fourteen years at Alcon, working in a variety of ophthalmology sales and marketing roles with escalating responsibility.